U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893328) titled 'A Real World Study About PMN' on March 19.
Brief Summary: We designed a randomized, controlled, multicenter clinical study to compare the efficacy and safety of rituximab combined with hormones versus rituximab monotherapy in the treatment of primary membranous nephropathy. At the same time, we conducted a real-world study on patients who did not meet the inclusion and exclusion criteria or were unwilling to enter the RCT cohort, to further observe the trial results in a broader population.
Study Start Date: Nov. 11, 2024
Study Type: OBSERVATIONAL
Condition:
Primary Membranous Nephropathy
Recruitment Status: RECRUITING
Sponso...